GLENMARK
Invest Now
Start SIP in
GLENMARK
Performance
- Low
- ₹1,423
- High
- ₹1,458
- 52 Week Low
- ₹1,000
- 52 Week High
- ₹1,831
- Open Price₹1,439
- Previous Close₹1,439
- Volume860,650
Investment Returns
- Over 1 Month + 6.99%
- Over 3 Month + 4.87%
- Over 6 Month -3.78%
- Over 1 Year + 37.77%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -230.5
- PEG Ratio
- -2.9
- Market Cap Cr
- 40,530
- P/B Ratio
- 4.8
- Average True Range
- 45.07
- EPS
- 0
- Dividend Yield
- 0.2
- MACD Signal
- -0.76
- RSI
- 53.46
- MFI
- 58.08
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,436.20
-2.3
(-0.16%)

-
- Bearish Moving Average 5
-
- Bullish Moving Average 11
- 20 Day
- ₹1,420.38
- 50 Day
- ₹1,425.33
- 100 Day
- ₹1,446.48
- 200 Day
- ₹1,423.64
Resistance and Support
1438.9
- R3 1,489.60
- R2 1,473.60
- R1 1,454.90
- S1 1,420.20
- S2 1,404.20
- S3 1,385.50
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-23 | Audited Results & Final Dividend | |
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results | |
2024-05-24 | Audited Results & Final Dividend |
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- Chairman & Managing Director
- Mr. Glenn Saldanha
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹1,436 As on 20 May, 2025 | 21:05
The Market Cap of Glenmark Pharmaceuticals is ₹40529.7 Cr As on 20 May, 2025 | 21:05
The P/E ratio of Glenmark Pharmaceuticals is -230.5 As on 20 May, 2025 | 21:05
The PB ratio of Glenmark Pharmaceuticals is 4.8 As on 20 May, 2025 | 21:05
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.